The regulation of vascular function by P2 receptors: Multiple sites and multiple receptors

Trends in Pharmacological Sciences

Volumn 19, Issue 3, 1998, Pages 99-107

  Boarder, Michael R ^a   Hourani, Susanna M O ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; PURINE P2 RECEPTOR;

BLOOD VESSEL FUNCTION; CARDIOVASCULAR FUNCTION; CELL TYPE; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; SECOND MESSENGER; THROMBOCYTE ACTIVATION;

EID: 0032033139     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01170-5     Document Type: Article

References (54)

1. 1 Sedaa, K. O., Bjur, R. and Westfall, D. P. (1989) J. Pharmacol. Exp. Ther. 252, 1060-1067
2. 2 Saiag, B. et al. (1995) Endothelium 2, 279-285
3. 3 Leon, C. et al. (1996) FEBS Lett. 403, 26-30
4. 4 Communi, D., Govaerts, C., Parmentier, M. and Boeynaems, J-M. (1997) J. Biol. Chem. 272, 31969-31973
5. 5 Lazarowski, E. R. et al. (1995) Br. J. Pharmacol. 116, 1619-1627
6. 6 Pearson, J. D., Slakey, L. L. and Gordon, J. L. (1983) Biochem. J. 214, 237-276
7. 7 Wilkinson, G. F., Purkiss, J. R. and Boarder, M. R. (1993) Br. J. Pharmacol. 108, 689-693
8. 8 Motte, S., Pirotton, S. and Boeynaems, J-M. (1993) Circ. Res. 72, 504-510
9. 9 Purkiss, J. R., Wilkinson, G. F. and Boarder, M. R. (1994) Br. J. Pharmacol. 111, 723-728
10. 10 Wilkinson, G. F., McKechnie, K., Dainty, I. and Boarder, M. R. (1994) J. Pharmacol. Exp. Ther. 268, 881-887
11. 11 Ralevic, V. and Burnstock, G. (1996) Br. J. Pharmacol 118, 428-434
12. 12 Purkiss, J. R., Wilkinson, G. F. and Boarder, M. R. (1993) Br. J. Pharmacol. 108, 1031-1037
13. 13 Frelin, C., Breittmayer, J. P. and Vigne, P. (1993) J. Biol. Chem. 268, 8787-8792
14. 14 Albert, J. L. et al. (1997) Br. J. Pharmacol. 122, 935-941
15. 15 Carter, T. D., Hallam, T. J., Cusack, N. J. and Pearson, J. D. (1988) Br. J. Pharmacol. 95, 1181-1190
16. 16 Carter, T. D., Hallam, T. J. and Pearson, J. D. (1989) Biochem. J. 262, 61-63
17. 17 Patel, V., Brown, C. and Boarder, M. R. (1996) Br. J. Pharmacol. 118, 123-130
18. 18 Patel, V., Brown, C., Goodwin, A., Wilkie, N. and Boarder, M. R. (1996) Biochem. J. 320, 221-226
19. 19 Schievella, A. R., Regier, M. K., Smith, W. L. and Lin, L-L. (1995) J. Biol. Chem. 270, 30749-30754
20. 20 Schalkwijk, C. G. et al. (1996) Biochem. J. 313, 91-96
21. 21 Hirata, K. I. et al. (1995) Hypertension 25, 180-185
22. 22 Brown, C. A., Patel, V., Wilkinson, G. and Boarder, M. R. (1996) Biochem. Pharmacol. 52, 1849-1854
23. 23 Hourani, S. M. O. and Hall, D. A. (1996) Ciba Found. Symp. 198, 52-69
24. 24 Mills, D. C. B. (1996) Thromb. Haemost. 76, 835-856
25. 25 Schörr, K. (1993) Platelets 4, 252-261
26. 26 Humphries, R. G., Robertson, M. J. and Leff, P. (1995) Trends Pharmacol. Sci. 16, 179-181
27. 27 Ohlmann, P. et al. (1995) Biochem. J. 312, 775-779
28. 28 Offermans, S., Toombs, C. F., Hu, Y-H. and Simon, M. I. (1995) Nature 389, 183-186
29. 29 Sage, S. O., Mahaut-Smith, M. P. and Rink, T. J. (1992) News Physiol. Sci. 7, 108-113
30. 30 MacKenzie, A. B., Mahaut-Smith, M. P. and Sage, S. O. (1996) J. Biol. Chem. 271, 2879-2881
31. 31 Vial, C., Hechler, B., Leon, C., Cazenave, J-P. and Gachet, C. (1997) Thromb. Haemost. 78, 1500-1504
32. 32 Evans, R. J. and Kennedy, C. (1994) Br. J. Pharmacol. 113, 853-860
33. 33 Vulchanova, L. et al. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8063-8067
34. 34 Hourani, S. M. O., Loizou, G. D. and Cusack, N. J. (1986) Eur. J. Pharmacol. 131, 99-103
35. 35 Trezise, D. J., Michel, A. D., Grahames, C. B. A., Khakh, B. S., Surprenant, A. and Humphrey, P. P. A. (1995) Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 603-609
36. 36 McLaren, G. J., Kennedy, C. and Sneddon, P. (1995) Eur. J. Pharmacol. 131, 99-103
37. 37 Schlüter, H. et al. (1994) Nature 367, 186-188
38. 38 Schlüter, H., Tepel, M. and Zidek, W. (1996) J. Auton. Pharmacol. 16, 357-362
39. 39 Charlton, S. J. et al. (1996) Br. J. Pharmacol. 119, 1301-1303
40. 40 Rubino, A. and Burnstock, G. (1996) Br. J. Pharmacol. 118, 1415-1420
41. 41 Miyagi, Y., Kobayashi, S., Nishimura, J., Fukui, M. and Kanaide, H. (1996) Br. J. Pharmacol. 118, 847-856
42. 42 Goetz, U., Da Prada, M. and Pletscher, A. (1971) J. Pharmacol. Exp. Ther. 178, 210-215
43. 43 Pacaud, P., Malam-Souley, R., Loirand, G. and Desgranges, C. (1995) Am. J. Physiol. 269, H30-H36
44. 44 Strobaek, D., Olesen, S-P., Christophersen, P. and Dissing, S. (1996) Br. J. Pharmacol. 118, 1645-1652
45. 45 Miyagi, Y. et al. (1996) Biochem. Biophys. Res. Commun. 222, 652-658
46. 46 Chang, K., Hanaoka, K., Kumada, M. and Takuwa, Y. (1995) J. Biol. Chem. 270, 26152-26158
47. 47 Burnstock, G. (1996) J. Auton. Pharmacol. 16, 295-302
48. 48 Starke, K., Von Kügelgen, I., Driessen, B. and Bültmann, R. (1996) Ciba Found. Symp. 198, 239-259
49. 49 Von Kügelgen, I., Stoffel, D., Schobert, A. and Starke, K. (1996) J. Auton. Pharmacol. 16, 413-416
50. 50 Von Kügelgen, I., Kurz, K. and Starke, K. (1993) Neuroscience 56, 263-267
51. 51 Shinozuka, K., Bjur, R. A. and Westfall, D. P. (1988) Naunyn-Schmiedeberg's Arch. Pharmacol. 338, 221-227
52. 52 Di Virgilio, F. et al. (1996) Drug Dev. Res. 39, 426-435
53. 53 Francheschi, C. et al. (1996) Drug Dev. Res. 39, 442-449
54. 54 Wilkie, N., Ng, L. L. and Boarder, M. R. (1997) Br. J. Pharmacol. 121, 209-216